| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $11.9M | +37.3% | +98.2% |
| SG&A Expense | $7.6M | -19.1% | -43.0% |
| Operating Income | -$19.5M | -8.1% | -1.0% |
| Pre-tax Income | -$18.0M | -12.8% | +12.9% |
| Net Income | -$18.0M | -12.8% | +12.9% |
| EPS (Basic) | -$0.21 | -23.5% | +19.2% |
| EPS (Diluted) | -$0.21 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $139.0M | -10.0% | -26.1% |
| Current Assets | $142.3M | -9.4% | -24.7% |
| Total Assets | $143.9M | -8.8% | -23.9% |
| Current Liabilities | $25.5M | +36.3% | +39.7% |
| Total Liabilities | $25.5M | +36.3% | +39.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.5M | — | — |
| Capital Expenditures | $96K | — | — |
| Investing Cash Flow | -$96K | — | — |
| Financing Cash Flow | $5.2M | — | — |
| Free Cash Flow | -$42.6M | — | — |
| -23.5% |
| +19.2% |
| $108.2M |
| -14.0% |
| -29.3% |